Literature DB >> 18928249

Structural characterization of a novel sulfated menaquinone produced by stf3 from Mycobacterium tuberculosis.

Cynthia M Holsclaw, Kimberly M Sogi, Sarah A Gilmore, Michael W Schelle, Michael D Leavell, Carolyn R Bertozzi, Julie A Leary.   

Abstract

Mycobacterium tuberculosis, the causative agent of tuberculosis, produces unique sulfated metabolites associated with virulence. One such metabolite from M. tuberculosis lipid extracts, S881, has been shown to negatively regulate the virulence of M. tuberculosis in mouse infection studies, and its cell-surface localization suggests a role in modulating host-pathogen interactions. However, a detailed structural analysis of S881 has remained elusive. Here we use high-resolution, high-mass-accuracy, and tandem mass spectrometry to characterize the structure of S881. Exact mass measurements showed that S881 is highly unsaturated, tandem mass spectrometry indicated a polyisoprene-derived structure, and characterization of synthetic structural analogs confirmed that S881 is a previously undescribed sulfated derivative of dihydromenaquinone-9, the primary quinol electron carrier in M. tuberculosis. To our knowledge, this is the first example of a sulfated menaquinone produced in any prokaryote. Together with previous studies, these findings suggest that this redox cofactor may play a role in mycobacterial pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18928249      PMCID: PMC2680727          DOI: 10.1021/cb800145r

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  22 in total

1.  Function of the cytochrome bc1-aa3 branch of the respiratory network in mycobacteria and network adaptation occurring in response to its disruption.

Authors:  Limenako G Matsoso; Bavesh D Kana; Paul K Crellin; David J Lea-Smith; Assunta Pelosi; David Powell; Stephanie S Dawes; Harvey Rubin; Ross L Coppel; Valerie Mizrahi
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

Review 2.  Sulfate metabolism in mycobacteria.

Authors:  Michael W Schelle; Carolyn R Bertozzi
Journal:  Chembiochem       Date:  2006-10       Impact factor: 3.164

3.  Altered expression profile of the surface glycopeptidolipids in drug-resistant clinical isolates of Mycobacterium avium complex.

Authors:  K H Khoo; E Jarboe; A Barker; J Torrelles; C W Kuo; D Chatterjee
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

4.  Mycobacterial lipid II is composed of a complex mixture of modified muramyl and peptide moieties linked to decaprenyl phosphate.

Authors:  Sebabrata Mahapatra; Tetsuya Yagi; John T Belisle; Benjamin J Espinosa; Preston J Hill; Michael R McNeil; Patrick J Brennan; Dean C Crick
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

5.  Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

Authors:  M Farzan; T Mirzabekov; P Kolchinsky; R Wyatt; M Cayabyab; N P Gerard; C Gerard; J Sodroski; H Choe
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

Review 6.  Long-chain multiple methyl-branched fatty acid-containing lipids of Mycobacterium tuberculosis: biosynthesis, transport, regulation and biological activities.

Authors:  Mary Jackson; Gustavo Stadthagen; Brigitte Gicquel
Journal:  Tuberculosis (Edinb)       Date:  2006-10-09       Impact factor: 3.131

7.  Decaprenyl diphosphate synthesis in Mycobacterium tuberculosis.

Authors:  Devinder Kaur; Patrick J Brennan; Dean C Crick
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

8.  A sulfated metabolite produced by stf3 negatively regulates the virulence of Mycobacterium tuberculosis.

Authors:  Joseph D Mougous; Ryan H Senaratne; Christopher J Petzold; Madhulika Jain; Dong H Lee; Michael W Schelle; Michael D Leavell; Jeffery S Cox; Julie A Leary; Lee W Riley; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

9.  Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy.

Authors:  M I Voskuil; K C Visconti; G K Schoolnik
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

10.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  29 in total

Review 1.  Dealing with the unknown: metabolomics and metabolite atlases.

Authors:  Benjamin P Bowen; Trent R Northen
Journal:  J Am Soc Mass Spectrom       Date:  2010-04-12       Impact factor: 3.109

Review 2.  Adenylating enzymes in Mycobacterium tuberculosis as drug targets.

Authors:  Benjamin P Duckworth; Kathryn M Nelson; Courtney C Aldrich
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 3.  The Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Hugues Ouellet; Jonathan B Johnston; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2009-07-25       Impact factor: 4.013

4.  The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.

Authors:  Kirsty J McLean; Pierre Lafite; Colin Levy; Myles R Cheesman; Natalia Mast; Irina A Pikuleva; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 5.  New targets and inhibitors of mycobacterial sulfur metabolism.

Authors:  Hanumantharao Paritala; Kate S Carroll
Journal:  Infect Disord Drug Targets       Date:  2013-04

6.  Allosteric regulation of menaquinone (vitamin K2) biosynthesis in the human pathogen Mycobacterium tuberculosis.

Authors:  Ghader Bashiri; Laura V Nigon; Ehab N M Jirgis; Ngoc Anh Thu Ho; Tamsyn Stanborough; Stephanie S Dawes; Edward N Baker; Esther M M Bulloch; Jodie M Johnston
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

Review 7.  Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Paul R Ortiz de Montellano
Journal:  J Inorg Biochem       Date:  2018-01-12       Impact factor: 4.155

8.  Functional redundancy of steroid C26-monooxygenase activity in Mycobacterium tuberculosis revealed by biochemical and genetic analyses.

Authors:  Jonathan B Johnston; Hugues Ouellet; Paul R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

9.  Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids.

Authors:  Mamadou Daffé; Dean C Crick; Mary Jackson
Journal:  Microbiol Spectr       Date:  2014

10.  Biochemical and structural characterization of CYP124: a methyl-branched lipid omega-hydroxylase from Mycobacterium tuberculosis.

Authors:  Jonathan B Johnston; Petrea M Kells; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.